Myomo Third Quarter 2021 Financial Results Feature Record Revenue
Revenue of $4.4 million up 128% over prior year, up 159% year-to-date Gross margin of 75% up 1,900 basis points over prior year Backlog increased to 177 units Conference call begins at 4:30 p.m. Eastern time today BOSTON, Mass. (November 10, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical […]
Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021
BOSTON, Mass., (November 3, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three and nine months ended September 30, 2021 on November 10, 2021 […]
Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants
BOSTON, Mass. (October 15, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced it has entered into agreements with certain of its holders of its existing 2020 investor warrants exercisable for 1,015,798 shares […]
Myomo, Inc. to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5th
BOSTON, Mass. (September 28, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will present at the […]
Myomo, Inc. Announces Granting of Patents in China and Hong Kong
Patents Expected to be Licensed to Newly Established Joint Venture Company in China BOSTON, Mass. (September 7, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the granting of patents in China and […]
Myomo, Inc. Announces Participation in Three September Investment Conferences
BOSTON, Mass. (September 2, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will participate in three […]
Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders
Revenue was $3.1 million, up 262% over prior year Gross margin was 71%, up 2,000 basis points over prior year Insurance authorizations and orders were a record 138 Conference call begins at 4:30 p.m. Eastern time today BOSTON, Mass. (August 9, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical […]
Myomo to Report Second Quarter 2021 Financial Results on August 9, 2021
BOSTON, Mass., (August 2, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three and six months ended June 30, 2021 on August 9, 2021 […]
Myomo Receives Accreditation From HQAA
BOSTON, Mass. (JULY 27, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Association on Accreditation (HQAA) has certified Myomo meets the accreditation requirements under the Social Security Act […]
Myomo, Inc. Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021
BOSTON, Mass. (July 23, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021. Read more.